Dr. Singh received her Ph.D. degree in Immunology from National Institute of Immunology, New Delhi, India in 2020. Her Ph.D. work focused on designing artificial tissue substitute to be used for organ regeneration, utilizing natural and organic polymers. She received fellowship from University of Toronto, Canada, to work at Ross Tilley Burn Centre of Sunnybrook Health Sciences Centre, Toronto, to advance her research on artificial dermal substitutes.

She did her postdoctoral training in the Department of Physiological Sciences, Oklahoma State University (OSU), where she extended her knowledge of organic polymer to develop multimodal particles for enhanced antigen presenting cell activation. Later, she served as research scientist and research assistant professor at OSU and focused her work on improving clinical outcomes of immunotherapies for cancer treatment. She was a part of a canine clinical trial team at OSU where she treated canine cancer patients with therapeutic ultrasound and immunological cell death inducing nanoparticles.

Dr. Singh has extensive experience with therapeutic ultrasound, cancer immunology, polymeric nano- and micro- particle formulations, biochemistry, molecular biology, protein structure and function, and has published her work in peer-reviewed journals. Her current work is focused on understanding molecular and immunological variations among cancer patients, and designing a treatment regime based on patient immune and demographic profile.